Microbot Medical logo

Microbot MedicalNASDAQ: MBOT

Profile

Sector:

Healthcare

Country:

United States

IPO:

25 March 1992

Next earnings report:

14 August 2024

Last dividends:

N/A

Next dividends:

N/A
$15.41 M
-75%vs. 3y high
21%vs. sector
-vs. 3y high
-vs. sector
-68%vs. 3y high
64%vs. sector
-vs. 3y high
-vs. sector

Price

after hours | Wed, 03 Jul 2024 20:48:41 GMT
$1.07+$0.09(+9.18%)

Dividend

No data over the past 3 years
No data over the past 3 years

Analysts recommendations

Institutional Ownership

MBOT Latest News

Microbot (MBOT) Inks a New Agreement to Begin Trial on LIBERTY
zacks.com04 July 2024 Sentiment: -

Microbot (MBOT) signs a clinical trial agreement with the Baptist Hospital of Miami for its LIBERTY Endovascular Robotic Surgical System as a part of its Investigational Device Exemption.

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
globenewswire.com17 June 2024 Sentiment: -

The Site Initiation Visit for the BWH clinical staff is complete and a shipment of LIBERTY investigational units was delivered The Site Initiation Visit for the BWH clinical staff is complete and a shipment of LIBERTY investigational units was delivered

Microbot Medical (MBOT) Files IDE to Start Human Clinical Study
Zacks Investment Research07 February 2024 Sentiment: POSITIVE

Microbot Medical (MBOT) files an IDE with the FDA, approval of which will enable the company to proceed with its human clinical study in the United States.

Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023
GlobeNewsWire08 September 2023 Sentiment: POSITIVE

The presentation follows successful extensive uses of the Company's endovascular robotic system in pre-clinical studies The presentation follows successful extensive uses of the Company's endovascular robotic system in pre-clinical studies

Microbot Medical spikes 150% on its Endovascular Surgical Robot
MarketBeat23 May 2023 Sentiment: POSITIVE

Microbot Medical Inc. NASDAQ: MBOT stock spiked more than 150% on a massive 194 million share volume on a successful pre-clinical animal study for its LIBERTY surgical robotic system. Shares hit a high of $4.37 intraday before closing at $3.19 on May 22, 2023.

What type of business is Microbot Medical?

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

What sector is Microbot Medical in?

Microbot Medical is in the Healthcare sector

What industry is Microbot Medical in?

Microbot Medical is in the Medical Instruments & Supplies industry

What country is Microbot Medical from?

Microbot Medical is headquartered in United States

When did Microbot Medical go public?

Microbot Medical initial public offering (IPO) was on 25 March 1992

What is Microbot Medical website?

https://www.microbotmedical.com

Is Microbot Medical in the S&P 500?

No, Microbot Medical is not included in the S&P 500 index

Is Microbot Medical in the NASDAQ 100?

No, Microbot Medical is not included in the NASDAQ 100 index

Is Microbot Medical in the Dow Jones?

No, Microbot Medical is not included in the Dow Jones index

When does Microbot Medical report earnings?

The next expected earnings date for Microbot Medical is 14 August 2024